BCM
FBIO icon

Bluefin Capital Management’s Fortress Biotech FBIO Stock Holding History

Bluefin Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,074
Closed -$256K – 527
2015
Q2 		$256K Buy
+5,074
New +$260K 0.02% 384

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bluefin Capital Management's FBIO Position: Q3 2015 in Review

Bluefin Capital Management sold out of Fortress Biotech (FBIO) in Q3 2015, closing a stake of 5,074 shares — an estimated $256K sold.

Bluefin Capital Management first reported a position in FBIO in Q2 2015 and held it in 1 quarter. The position peaked at $256K in Q2 2015. 39 funds tracked by Wall St. Rank hold FBIO as of Q3 2015.

  • Bluefin Capital Management reported no remaining Fortress Biotech position as of Q3 2015 after selling out during the quarter.
  • Bluefin Capital Management sold 5,074 Fortress Biotech shares in Q3 2015, an estimated $256K.
  • Bluefin Capital Management first reported a position in Fortress Biotech in Q2 2015 and held it in 1 quarter.
  • Bluefin Capital Management's Fortress Biotech position peaked at $256K in Q2 2015.
  • 39 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2015.

Based on Bluefin Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.